» Articles » PMID: 2818579

Amphotericin B and Nystatin Show Different Activities on Sterol-free Vesicles

Overview
Publisher Elsevier
Specialty Biochemistry
Date 1989 Oct 31
PMID 2818579
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

It has generally been assumed that the polyene antibiotics Nystatin and Amphotericin B cause membrane damage by the same mechanism. However, using kinetic fluorescence methods we have found that AmB and Nystatin have very different activities on sterol-free dioleoyl phosphatidylcholine and egg phosphatidylcholine small unilamellar vesicles. At very low AmB concentrations (less than 1/1000 lipids in egg phosphatidylcholine) significant K+ permeability enhancement is observed. However, even at very high Nystatin to lipid ratios (1/100) very little K+ current is induced, particularly in dioleoyl phosphatidylcholine vesicles. The novel technique described here uses a K+/H+ exchange mechanism to detect minute transmembrane K+ currents by monitoring internal membrane vesicle pH changes with pyranine.

Citing Articles

The Role of Signaling via Aqueous Pore Formation in Resistance Responses to Amphotericin B.

Cohen B Antimicrob Agents Chemother. 2016; 60(9):5122-9.

PMID: 27381391 PMC: 4997855. DOI: 10.1128/AAC.00878-16.


Antifungal Activity of Amphotericin B Conjugated to Nanosized Magnetite in the Treatment of Paracoccidioidomycosis.

Saldanha C, Garcia M, Iocca D, Rebelo L, Souza A, Bocca A PLoS Negl Trop Dis. 2016; 10(6):e0004754.

PMID: 27303789 PMC: 4909273. DOI: 10.1371/journal.pntd.0004754.


Effect of membrane structure on the action of polyenes II: nystatin activity along the phase diagram of ergosterol- and cholesterol-containing POPC membranes.

Gonzalez-Damian J, Ortega-Blake I J Membr Biol. 2010; 237(1):41-9.

PMID: 20871987 DOI: 10.1007/s00232-010-9301-2.


Cholesterol and ergosterol influence nystatin surface aggregation: relation to pore formation.

Coutinho A, Silva L, Fedorov A, Prieto M Biophys J. 2004; 87(5):3264-76.

PMID: 15315952 PMC: 1304795. DOI: 10.1529/biophysj.104.044883.


Salvage treatment with amphotericin B in progressive human alveolar echinococcosis.

Reuter S, Buck A, Grebe O, Nussle-Kugele K, Kern P, Manfras B Antimicrob Agents Chemother. 2003; 47(11):3586-91.

PMID: 14576122 PMC: 253803. DOI: 10.1128/AAC.47.11.3586-3591.2003.